Experience the interactive Multichannel News Release in the provided link. The interactive video showcases La La offering a personal and professional perspective on how plaque psoriasis impacts her life and the importance of advocating for effective treatment options. La La shares her experience with managing plaque psoriasis and the importance of open communication with healthcare providers to find suitable treatments.
Plaque psoriasis is often misunderstood as a skin condition but is actually an autoimmune disease characterized by inflammation. Research indicates a discrepancy between patient perception of the severity of their condition and the assessment by healthcare providers. While topical treatments like creams and ointments provide relief, they only address symptoms and not the underlying inflammation.
Board-certified dermatologist Meagen McCusker emphasizes the uniqueness of each patient’s experience with plaque psoriasis and the availability of various treatment options tailored to individual needs. She encourages patients to communicate effectively with their doctors to find treatment options that address their specific symptoms and lifestyle.
To engage with La La’s video, access resources for discussing plaque psoriasis treatment with healthcare providers, and learn about oral treatment option Otezla, visit MomentsWithLaLa.com. Amgen is dedicated to providing affordable access to Otezla for plaque psoriasis patients. For more information, visit Otezla.com.
Psoriasis is a chronic condition characterized by rapid skin cell production, resulting in red, scaly, and itchy patches. Approximately 125 million people worldwide, including over 8 million in the United States, have psoriasis, with about 80% experiencing plaque psoriasis.
Otezla (apremilast) is an oral treatment for plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet’s Disease. Since its FDA approval in 2014, Otezla has been prescribed to over 1 million patients globally. It is essential to consult a healthcare provider before starting Otezla treatment.
Amgen is a leading biotechnology company specializing in innovative medicines for challenging diseases. With a focus on cancer, heart disease, osteoporosis, inflammatory diseases, and rare conditions, Amgen continues to push the boundaries of medical innovation. Recognized for its innovative achievements and commitment to excellence, Amgen is dedicated to improving patient outcomes globally.
For inquiries or more information, please contact Amgen at 609-251-1407 (media) or visit Amgen’s official website. Source: Amgen.
